Evidence map›Paper›PMID 39721581›Full record

ArticleMolecular cell2025

LDB1 establishes multi-enhancer networks to regulate gene expression.

Nicholas G Aboreden, Jessica C Lam, Viraat Y Goel, Siqing Wang, Xiaokang Wang, Susannah C Midla, Alma Quijano, Cheryl A Keller, Belinda M Giardine, Ross C Hardison and 3 more

Abstract read
In one paragraph

Article in Molecular cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Facilitators may represent a new class of regulatory elements.Current opinion in genetics & development · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Nicholas G AboredenPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jessica C LamPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Viraat Y GoelDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Siqing WangDivision of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Xiaokang WangDivision of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Susannah C MidlaDivision of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Alma QuijanoPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Cheryl A KellerDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Belinda M GiardineDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Ross C HardisonDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Haoyue ZhangInstitute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
Anders S HansenDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Gerd A BlobelPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: blobel@chop.edu.

Funding

Transcriptional Networks Controlling Erythroid DifferentiationR01DK054937 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Gerd A Blobel · 1999 to 2026
$12.8M
Training Program in Computational GenomicsT32HG000046 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JUNHYONG KIM, Mingyao Li · 1999 to 2026
$9.5M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008216 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI EPSTEIN, DOUGLAS J · 1987 to 2023
$8.3M
VISION: ValIdated Systematic IntegratiON of epigenomic dataR24DK106766 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI BLOBEL, GERD A, BODINE, DAVID M. · 2016 to 2020
$6.2M
Engineering and Imaging 3D genome structure-function dynamics across time scalesU01DK127405 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BLOBEL, GERD A, PHILLIPS-CREMINS, JENNIFER ELIZABETH · 2020 to 2024
$5.7M
Roles of CBP &PCAF During Hematopoietic DifferentiationR01DK058044 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · 2002 to 2023
$4.5M
Investigating the role of Ldb1 in chromatin architecture and transcription during erythroid cell state transitionsF31DK136200 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ABOREDEN, NICHOLAS · 2024 to 2024
$49k
Interrogating YY1's role in chromatin organization during erythroid cell state transitionsF30DK132824 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAM, JESSICA · 2022 to 2022
$33k
NHGRI NIH HHS T32 HG000046NIDDK NIH HHS F30 DK132824NIDDK NIH HHS F31 DK136200NIDDK NIH HHS R01 DK054937NIDDK NIH HHS R01 DK058044NIDDK NIH HHS R24 DK106766NIDDK NIH HHS U01 DK127405NIGMS NIH HHS T32 GM008216
6 · The paper itself

Abstract

How specific enhancer-promoter pairing is established remains mostly unclear. Besides the CTCF/cohesin machinery, few nuclear factors have been studied for a direct role in physically connecting regulatory elements. Using a murine erythroid cell model, we show via acute degradation experiments that LDB1 directly and broadly promotes connectivity among regulatory elements. Most LDB1-mediated contacts, even those spanning hundreds of kb, can form in the absence of CTCF, cohesin, or YY1 as determined using multiple degron systems. Moreover, an engineered LDB1-driven chromatin loop is cohesin independent. Cohesin-driven loop extrusion does not stall at LDB1-occupied sites but aids the formation of a subset of LDB1-anchored loops. Leveraging the dynamic reorganization of nuclear architecture during the transition from mitosis to G1 phase, we observe that loop formation and de novo LDB1 occupancy correlate and can occur independently of structural loops. Tri-C and Region Capture Micro-C reveal that LDB1 organizes multi-enhancer networks to activate transcription. These findings establish LDB1 as a driver of spatial connectivity.

Indexed as

DNA-Binding ProteinsEnhancer Elements, GeneticErythroid CellsGene Expression RegulationGene Regulatory NetworksAnimalsCCCTC-Binding FactorCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsG1 PhaseHumansLIM Domain ProteinsMiceMitosisCCCTC-Binding FactorCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsCtcf protein, mouseDNA-Binding ProteinsLdb1 protein, mouseLIM Domain ProteinsYy1 protein, mouseYY1 Transcription Factorchromatin architecture, enhancer, LDB1, looping, CTCF, cohesin, YY1, cell cycle, hub, LMO2

Identifiers

PMID39721581
PMCPMC11741933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.